PCM
KDNY

Piermont Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Piermont Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,160
Closed -$351K – 277
2017
Q2 		$351K Sell
6,160
-1,020
-14% -$58.1K 0.1% 243
2017
Q1 		$386K Buy
+7,180
New +$386K 0.09% 239